Among those with BMI loss >10%, APOE ɛ4 carriers also showed a higher risk of dementia compared with noncarriers (HR = 1.93, 95% CI 0.79–4.41, p = .129), albeit not statistically significant. This evidence concerns the gene APOE and dementia.